The stock of Port Erin Biopharma Investments Ltd (LON:PEBI) is a huge mover today! The stock increased 4.67% or GBX 0.26 on November 22, hitting GBX 5.89. About 1,358 shares traded hands. Port Erin Biopharma Investments Ltd (LON:PEBI) has risen 25.70% since April 21, 2016 and is uptrending. It has outperformed by 21.14% the S&P500.
The move comes after 7 months negative chart setup for the GBX 1.28M company. It was reported on Nov, 22 by Barchart.com. We have GBX 5.42 PT which if reached, will make LON:PEBI worth GBX 102,400 less.
More news for Port Erin Biopharma Investments Ltd (LON:PEBI) were recently published by: Prnewswire.com, which released: “Bontan changes its name to Portage Biotech Inc. and jurisdiction to BVI” on July 31, 2013. Reuters.com‘s article titled: “Port Erin Biopharma Investments Ltd announces no dividend” and published on March 31, 2014 is yet another important article.
Port Erin Biopharma Investments Limited invests in the biotechnology and biopharmaceutical sector. The company has a market cap of 1.28 million GBP. The Firm focuses on creating value for shareholders through investing in companies that have the potential to generate revenues through the development of biopharmaceutical drugs. It currently has negative earnings. The Firm invests in equity and equity-related products in both quoted companies, which offer the benefits of liquidity, and in unquoted companies, which offers the additional capital gains upon completion of an Initial Public Offering .
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.